Schedule 13D ownership disclosure

MEREO BIOPHARMA GROUP PLC

Security class unavailable · CUSIP: 589492107

Event date: 2023-11-03

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
13.3200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-114479
Form type
SC 13D/A
Filer
Mereo BioPharma Group plc
CIK
CIK 1719714
Filed
Nov 06, 2023
Reporting period
Nov 03, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub